[2]S. Palaian, M. Prabhu, and P. R. Shankar, "Patient counseling by pharmacist-a focus on chronic illness," Pak J Pharm Sci, vol. 19, no. 1, pp. 65-72, 2006.
[3]J. G. Allinson, R. J. Dansereau, and A. Sakr, "The effects of packaging on the stability of a moisture sensitive compound," International journal of pharmaceutics, vol. 221, no. 1-2, pp. 49-56, 2001.
[4]k. s. d. maryam Akhavan, "The Impact of Patients' Satisfaction (Level of Expectations, Communication with the Pharmacist, Physical Facilities, Drug Packaging and Consultations) from Pharmaceutical Services During the Covid-19 Pandemic," Packaging science and art, vol. 13, no. 51, pp. 21-32, 2023. [Online]. Available:
https://packaging.ihu.ac.ir/article_207810_95b2cae6541220de08aeada39eb1514d.pdf.
[5]B. K. Zedler, P. Kakad, S. Colilla, L. Murrelle, and N. R. Shah, "Does packaging with a calendar feature improve adherence to self-administered medication for long-term use? A systematic review," Clinical therapeutics, vol. 33, no. 1, pp. 62-73, 2011.
[6]E. Menditto et al., "Patient centric pharmaceutical drug product design—The impact on medication adherence," Pharmaceutics, vol. 12, no. 1, p. 44, 2020.
[7]H. P. McDonald, A. X. Garg, and R. B. Haynes, "Interventions to enhance patient adherence to medication prescriptions: scientific review," Jama, vol. 288, no. 22, pp. 2868-2879, 2002.
[9]M. Alagala, B. Bagbi, and A. Shaleye, "Impact of pharmaceutical packaging on consumer buying behaviour of otc drugs in port harcourt, Nigeria," Pharma Innov J, vol. 7, pp. 90-5, 2018.
[10]M. M. Hussein, "Design features of medicine box packaging for children," Al-Academy, no. 101, pp. 21-38, 2021.
[12]M. R. Mahdi Nasrollahi, Fathi Aliasghar, keshavarz shahbaz, somayeh Razi, Moheb seraj, Ali Tizroo,, "Identifying and Distinguishing the Effect of Packaging and Advertisements on instant shopping by Considering the Brand Equity (Case Study: Herbal Tea Products)," Packaging science and art, vol. 13, no. 51, pp. 33-45, 2023. [Online]. Available:
https://packaging.ihu.ac.ir/article_207794_7caf677f6c41b724aa5db25971e4ea62.pdf.
[13]J. Dunkey, "Health Promotion in midwifery: A ressource for health Professionals. An imprint of Harcourt publishers Ltd," ed: Bailiere Tindall, London, 2000.
[14]M. M. Deliya and B. J. Parmar, "Role of packaging on consumer buying behavior–patan district," global Journal of management and Business research, vol. 12, no. 10, pp. 49-67, 2012.
[15]W. H. Shrank and J. Avorn, "Educating patients about their medications: the potential and limitations of written drug information," Health affairs, vol. 26, no. 3, pp. 731-740, 2007.
[16]R. W. Soller and J. M. Lightwood, "Comparison of the packaging and labeling of Target ClearRx with conventional prescription drug packaging and labeling," Journal of the American Pharmacists Association, vol. 47, no. 4, pp. 484-490, 2007.
[17]L. A. Morris and J. A. Halperin, "Effects of written drug information on patient knowledge and compliance: a literature review," (in eng), Am J Public Health, vol. 69, no. 1, pp. 47-52, Jan 1979, doi: 10.2105/ajph.69.1.47.
[18]J. L. Wagner and E. McCarthy, "International differences in drug prices," Annu. Rev. Public Health, vol. 25, pp. 475-495, 2004.
[19]E. Kobayashi, H. Karigome, T. Sakurada, N. Satoh, and S. Ueda, "Patients’ attitudes towards generic drug substitution in Japan," Health policy, vol. 99, no. 1, pp. 60-65, 2011.
[20]R. A. Schaut and W. P. Weeks, "Historical review of glasses used for parenteral packaging," PDA journal of pharmaceutical science and technology, vol. 71, no. 4, pp. 279-296, 2017.
[21]Pareek and A. Khunteta, "Pharmaceutical packaging: current trends and future," Int J Pharm Pharm Sci, vol. 6, no. 6, pp. 480-485, 2014.
[22] R. J. Hilsden, C. M. Scott, and M. J. Verhoef, "Complementary medicine use by patients with inflammatory bowel disease," The American journal of gastroenterology, vol. 93, no. 5, pp. 697-701, 1998.
[23]J. M. Fouladbakhsh, "Gender, symptom experience, and use of complementary and alternative medicine practices among cancer survivors in the US cancer population," Number 1/January 2010, vol. 37, no. 1, pp. E7-E15, 2009.
[24]B. Roullet and O. Droulers, "Pharmaceutical packaging color and drug expectancy," ACR North American Advances, 2005.
[25]E. Hellier, M. Tucker, N. Kenny, A. Rowntree, and J. Edworthy, "Merits of using color and shape differentiation to improve the speed and accuracy of drug strength identification on over-the-counter medicines by laypeople," Journal of patient safety, vol. 6, no. 3, pp. 158-164, 2010.
[27]C. Spence, "The multisensory design of pharmaceuticals and their packaging," Food Quality and Preference, vol. 91, p. 104200, 2021.
[29]C. M. Marando, L. K. Seibold, J. R. SooHoo, M. B. Pantcheva, P. Y. Ramulu, and M. Y. Kahook, "The utility of cap color and bottle characteristics for topical glaucoma therapy," Ophthalmology, vol. 122, no. 12, pp. 2577-2578, 2015
[30]M. Shukla, R. Misra, and D. Singh, "Exploring relationship among semiotic product packaging, brand experience dimensions, brand trust and purchase intentions in an Asian emerging market," Asia Pacific Journal of Marketing and Logistics, vol. 35, no. 2, pp. 249-265, 2022.
[31]J. Park, K. Motoki, A. Pathak, and C. Spence, "A sound brand name: The role of voiced consonants in pharmaceutical branding," Food Quality and Preference, vol. 90, p. 104104, 2021.
[32]D. Rusic et al., "Evaluation of accordance of antibiotics package size with recommended treatment duration of guidelines for sore throat and urinary tract infections," Antimicrobial Resistance & Infection Control, vol. 8, pp. 1-12, 2019.
[33]H. Kauppinen‐Räisänen, "The impact of extrinsic and package design attributes on preferences for non‐prescription drugs," Management Research Review, vol. 33, no. 2, pp. 161-173, 2010.
[34]D. R. Jenke, C. L. Stults, D. M. Paskiet, D. J. Ball, and L. M. Nagao, "Materials in manufacturing and packaging systems as sources of elemental impurities in packaged drug products: a literature review," PDA journal of pharmaceutical science and technology, vol. 69, no. 1, pp. 1-48, 2015.
[35]E. C. van Geffen, E. Meuwese, D. Philbert, and M. L. Bouvy, "Problems with medicine packages: experiences reported to a Dutch medicine reporting system," Annals of Pharmacotherapy, vol. 44, no. 6, pp. 1104-1109, 2010.
)
